Skip to main content

Year: 2026

UID and AEG ID Combine to Expand Industrial RFID Solutions Across North America

KENOSHA, Wis. and ULM, Germany, June 12, 2026 (GLOBE NEWSWIRE) — Unified Information Devices, Inc. (UID), a leader in RFID- enabled monitoring for medical research, today announced that it has completed the acquisition of AEG Identifikationssysteme GmbH (AEG ID), including its headquarters in Ulm, Germany, and manufacturing operations in the Czech Republic. As demand for automation, traceability, and real-time operational intelligence continues to grow across manufacturing, healthcare, semiconductor production, and animal health, the acquisition expands UID’s manufacturing capabilities and creates a unified platform to bring RFID innovations to Europe and North America. “North America remains one of the world’s largest markets for industrial automation, traceability, and RFID-enabled asset intelligence,” said Craig Jordan,...

Continue reading

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced that its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s (i) 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) (the “Series A Preferred Stock”) (984,000 shares outstanding, CUSIP No. 98419J305) and (ii) depositary shares representing its 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO) (represented by 1,760,500 Depositary Shares) (the “Series B Preferred Stock”, and together with the Series A Preferred Stock, the “Preferred Stock”) (CUSIP No. 98419J404). In addition, on July 14, 2026 (the “Redemption Date”), it will redeem all outstanding shares of Preferred Stock, in each case pursuant to Section 5(b) of the applicable...

Continue reading

Monolithic Power Systems Announces Second Quarter 2026 Dividend

SCHAFFHAUSEN, Switzerland, June 12, 2026 (GLOBE NEWSWIRE) — Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a global company that provides high-performance, semiconductor-based power electronics solutions, announced today its second quarter dividend of $2.00 per common share to all stockholders of record as of the close of business on June 30, 2026. The dividend will be paid on July 15, 2026. Safe Harbor Statement This news release includes “forward-looking statements” intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our current expectations, estimates and projections about our business and industry, management’s beliefs, and certain assumptions made by us, all of which are subject to change. Forward-looking...

Continue reading

F&M Bank Launches 2nd Annual “Great Briefcase Hunt” with $10,000 Prize

Six clues. One hidden briefcase. A community adventure returns. ARCHBOLD, Ohio, June 12, 2026 (GLOBE NEWSWIRE) — F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO), is bringing back one of summer’s most anticipated community adventures: The Great Briefcase Hunt. Beginning June 15, the community across the F&M footprint will once again have the chance to follow weekly clues in search of a hidden briefcase worth $10,000 – with $5,000 awarded to the winner and $5,000 donated to a local charity from an approved F&M charity list. After generating excitement across communities in 2025, The Great Briefcase Hunt returns bigger, bolder, and ready to spark another summer of mystery, teamwork, and adventure. Participants will work together to solve six clues that...

Continue reading

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

The new VENTANA PTEN (SP218) RxDx Assay fulfils an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP In prostate cancer, PTEN protein loss is associated with faster disease progression and reduced benefit from current standard-of-care treatments1 The FDA approval reinforces Roche’s leadership in companion diagnostics and its ongoing commitment to expanding personalised healthcare to improve patient outcomesBasel, 12 June 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the VENTANAⓇ PTEN (SP218) RxDx Assay is the first immunohistochemistry (IHC) companion diagnostic test to receive U.S. Food and Drug Administration (FDA) approval for determining PTEN protein loss, also known as PTEN deficiency, in tumours of patients with prostate...

Continue reading

Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company’s securities in a registered direct offering (the “Offering”) consisting of up to 1,133,332 of the Company’s Class A ordinary shares, par value $0.001 each (the “Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A ordinary shares (the “Warrant Shares”), at a combined purchase price of $1.50 per Share and Pre-Funded Warrant. The gross proceeds to the Company from this Offering are expected to be approximately $2.0 million. The Offering is expected to close...

Continue reading

SL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global Market

Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT” Transaction provides strategic capital to advance proprietary Gamma delta T cell-based “off-the-shelf” cellular therapies for solid tumor indications, including pancreatic and brain cancers Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growthTAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) — SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the closing of its previously announced business combination with Horizon Space Acquisition II Corp. (Nasdaq: HSPT) (“Horizon Space”), a...

Continue reading

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) — Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately. Votes must be received by 11:59 p.m., Eastern Time, on June 14, 2026, to be voted at the Annual Meeting. In order to ensure that there is a quorum required for the shareholders’ meeting that is scheduled to take place tomorrow, June 15, 2026, at 10 a.m. Eastern Time. At the time of this press release, approximately 42% of shares have been voted. For the company to hold the shareholder meeting, a minimum of 50% of shares must be voted. If the Company does not receive sufficient votes to establish a quorum, it may need to adjourn and reconvene the shareholder meeting, which would result in high additional costs....

Continue reading

Leo International Precision Health AG Announces Results of the 2026 Annual General Meeting

Leo International Precision Health AG Announces Results of the 2026 Annual General Meeting Planegg / Martinsried, Germany, June 12, 2026 – Leo International Precision Health AG (“LIPH” or the “Company”, ticker symbol: LEOW), a holding company building a global integrated AI-driven healthcare ecosystem, today held its Annual General Meeting (AGM) as an in-person event. During the AGM, the Management Board reported on the Company’s development in fiscal year 2025 as well as the current business performance and strategic objectives for the ongoing fiscal year. Key topics included the establishment of the integrated precision health portfolio, the successful contribution of the first six portfolio companies, and the planned further expansion through additional acquisitions in Europe and Asia. The Management and Supervisory Board answered all...

Continue reading

Pilgrim’s Announces Investment in Ellijay, Georgia to Strengthen Operations and Align With Growing Consumer Demand

GREELEY, Colo., June 12, 2026 (GLOBE NEWSWIRE) — Pilgrim’s today announced a strategic investment to expand and modernize its Ellijay, Georgia poultry facility, strengthening the company’s ability to meet evolving consumer preferences, support key customer growth, and enhance long-term operational excellence. The approximately $75 million investment will increase harvesting and portioning capacity in Ellijay and enable the facility to produce a broader mix of higher-value, boneless chicken products — including those used in popular chicken sandwiches, tenders, and other fast-growing categories. This investment supports key customers’ growth plans, through a change in Pilgrim’s portfolio mix in Ellijay. “As consumer demand shifts and our customers grow, we are investing to ensure our operations are positioned for the future,” said...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.